2-(Furan-2-yl)-1,3-thiazole-5-carbaldehyde | 1206972-65-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 2-(Furan-2-yl)-1,3-thiazole-5-carbaldehyde
• CAS: 1206972-65-7
• 化学式: C₈H₅NO₂S
• mdl: MFCD14615210
• 分子量: 179.2
• InChiKey: UYZBMUFPDLVHSA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  71.3
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-(Furan-2-yl)-1,3-thiazole-5-carbaldehyde 在 N-溴代丁二酰亚胺(NBS) 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 以95 %的产率得到2-(5-Bromofuran-2-yl)-1,3-thiazole-5-carbaldehyde
  参考文献：
  名称：

  COMPOUND AND ITS USE IN ORGANIC ELECTRONIC DEVICES

  摘要：

  A compound is provided that can be evaporated largely without residue in a vacuum. Because the compound can be evaporated largely without residue in a vacuum, the compound is thus suitable for vacuum processing for producing solar cells. The compound advantageously demonstrates a blue shift in the absorption spectrum. An organic electronic device including the compound is also provided.

  公开号：

  US20240109878A1
• 作为产物：
  描述：

  2-(三丁基锡烷基)呋喃 、 2-溴-5-甲醛基噻唑 在 四(三苯基膦)钯 作用下， 以 甲苯 为溶剂， 以64 %的产率得到2-(Furan-2-yl)-1,3-thiazole-5-carbaldehyde
  参考文献：
  名称：

  COMPOUND AND ITS USE IN ORGANIC ELECTRONIC DEVICES

  摘要：

  A compound is provided that can be evaporated largely without residue in a vacuum. Because the compound can be evaporated largely without residue in a vacuum, the compound is thus suitable for vacuum processing for producing solar cells. The compound advantageously demonstrates a blue shift in the absorption spectrum. An organic electronic device including the compound is also provided.

  公开号：

  US20240109878A1

文献信息

• [EN] HETEROARYLALKANOIC ACIDS AS INTEGRIN RECEPTOR ANTAGONISTS<br/>[FR] ACIDES HETEROARYLALCANOIQUES EN TANT QU'ANTAGONISTES DU RECEPTEUR D'INTEGRINE
  申请人：PHARMACIA CORP

  公开号：WO2004058254A1

  公开（公告）日：2004-07-15

  The present invention relates to pharmaceutical compositions comprising compounds of the Formula I, or a pharmaceutically acceptable salt thereof, and methods of selectively inhibiting or antagonizing the ανβ3 and/or the ανβ5 integrin without significantly inhibiting the ανβ6 integrin.